These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2365187)

  • 1. The effects of indomethacin on gastroduodenal morphology and mucosal pH gradient in the healthy human stomach.
    Shorrock CJ; Prescott RJ; Rees WD
    Gastroenterology; 1990 Aug; 99(2):334-9. PubMed ID: 2365187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal adaptation to indomethacin induced gastric damage in man--studies on morphology, blood flow, and prostaglandin E2 metabolism.
    Shorrock CJ; Rees WD
    Gut; 1992 Feb; 33(2):164-9. PubMed ID: 1541410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual effect of female sex steroids on drug-induced gastroduodenal ulcers in the rat.
    Drago F; Montoneri C; Varga C; Làszlò F
    Life Sci; 1999; 64(25):2341-50. PubMed ID: 10374897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketotifen--old drug, new indication: reduction of gastric mucosal injury.
    Eliakim R; Karmeli F; Rachmilewitz D
    Scand J Gastroenterol; 1993 Mar; 28(3):202-4. PubMed ID: 8446844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ranitidine ameliorates acemetacin and indomethacin-induced changes of the gastroduodenal mucosa, without modifying the pharmacokinetic behavior of both antirheumatic drugs].
    Müller P; Dammann HG; Langer M; Leucht U; Simon B
    Z Gastroenterol; 1989 Feb; 27(2):83-6. PubMed ID: 2658392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No correlation between indomethacin-induced gastroduodenal damage and inhibition of gastric prostanoid synthesis.
    Goldin E; Stalnikowicz R; Wengrower D; Eliakim R; Fich A; Ligumsky M; Karmeli F; Rachmilewitz D
    Aliment Pharmacol Ther; 1988 Aug; 2(4):369-75. PubMed ID: 2979261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroduodenal mucosal defence mechanisms and the action of non-steroidal anti-inflammatory agents.
    Garner A; Allen A; Rowe PH
    Scand J Gastroenterol Suppl; 1987; 127():29-34. PubMed ID: 3303291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroduodenal lesions induced by naproxen. An endoscopic evaluation of regional differences and natural course.
    Aabakken L; Osnes M
    Scand J Gastroenterol; 1990 Dec; 25(12):1215-22. PubMed ID: 2274742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indomethacin-induced gastroduodenal damage is not affected by cotreatment with ranitidine.
    Stalnikowicz R; Goldin E; Fich A; Wengrower D; Eliakim R; Ligumsky M; Rachmilewitz D
    J Clin Gastroenterol; 1989 Apr; 11(2):178-82. PubMed ID: 2786899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct effects of tetragastrin in rat gastroduodenal mucosa on mucin content and mucosal protective action against histamine-induced injury.
    Komuro Y; Ishihara K; Kojima Y; Saigenji K; Hotta K
    Dig Dis Sci; 1998 May; 43(5):1050-6. PubMed ID: 9590421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of gastroduodenal mucosal protection.
    Shorrock CJ; Rees WD
    Am J Med; 1988 Feb; 84(2A):25-34. PubMed ID: 3279766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a new non-steroidal anti-inflammatory combination of a histamine H2 antagonist and indomethacin on gastroduodenal mucosal membrane in rat.
    Segawa Y; Omata T; Abe T; Tsuzuike N; Itokazu Y; Yoshida K; Ueda I
    Arzneimittelforschung; 1992 Oct; 42(10):1232-5. PubMed ID: 1361736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroduodenal mucosal protection.
    Allen A; Flemström G; Garner A; Kivilaakso E
    Physiol Rev; 1993 Oct; 73(4):823-57. PubMed ID: 8415927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An endoscopic comparison of gastroduodenal injury with over-the-counter doses of ketoprofen and acetaminophen.
    Lanza FL; Codispoti JR; Nelson EB
    Am J Gastroenterol; 1998 Jul; 93(7):1051-4. PubMed ID: 9672328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct and adaptive cytoprotection.
    Jacobson ED
    Dig Dis Sci; 1986 Feb; 31(2 Suppl):28S-31S. PubMed ID: 3943454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 24 hours of aspirin, Bufferin, paracetamol and placebo on normal human gastroduodenal mucosa.
    Hoftiezer JW; O'Laughlin JC; Ivey KJ
    Gut; 1982 Aug; 23(8):692-7. PubMed ID: 7095565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute damage of gastroduodenal mucosa by acetylsalicylic acid: no prolonged protection by antacids.
    Berstad K; Haram EM; Weberg R; Berstad A
    Aliment Pharmacol Ther; 1989 Dec; 3(6):585-90. PubMed ID: 2518872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of indomethacin induced gastroduodenal mucosal injury and gastrointestinal symptoms with cimetidine in normal subjects.
    Frank WO; Wallin BA; Berkowitz JM; Kimmey MB; Palmer RH; Rockhold F; Young MD
    J Rheumatol; 1989 Sep; 16(9):1249-52. PubMed ID: 2810283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of effects of calcium carbasalate and aspirin on gastroduodenal mucosal damage in human volunteers.
    Murray FE; Hudson N; Atherton JC; Cole AT; Scheck F; Hawkey CJ
    Gut; 1996 Jan; 38(1):11-4. PubMed ID: 8566836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.